Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
申请人:Merck Sharp & Dohme Corp.
公开号:US07989472B2
公开(公告)日:2011-08-02
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
本发明揭示了胰高血糖素受体拮抗剂化合物。该化合物可用于治疗2型糖尿病及相关疾病。本发明还包括药物组合物和治疗方法。